Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Li-Juan KangYu-Mei Feng

Abstract

FOXF2 and FOXQ1, forkhead box transcription factor superfamily members, are encoded by neighboring genes located on human chromosome 6p25.3 and play opposite roles in epithelial-mesenchymal transition (EMT) and metastasis in basal-like breast cancer (BLBC). However, the relationship between FOXF2 and FOXQ1 in cancer remains unknown. Here, we found mutual transcriptional repression between FOXF2 and FOXQ1, and the reciprocal negative feedback loop controlled EMT, aggressiveness, and chemoresistance in BLBC cells. We further demonstrated that FOXF2 recruited nuclear receptor corepressor 1 and histone deacetylase 3 to the FOXQ1 promoter to inhibit its transcription in BLBC cells, but FOXQ1 did not exert such an effect on FOXF2. Our findings reveal novel mechanisms underlying the determination of BLBC aggressiveness and the transrepressive function of FOXF2 in a basal-like cell subtype-specific manner. Therefore, blocking the vicious cycle of the abnormal reciprocal feedback loop between FOXF2 and FOXQ1 to induce cell differentiation and restore tissue homeostasis is a promising strategy for the treatment of aggressive BLBC.-Kang, L.-J., Yu, Z.-H., Cai, J., He, R., Lu, J.-T., Hou, C., Wang, Q.-S., Li, X.-Q., Zhang, R., Feng, Y.-M. ...Continue Reading

References

Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y D WenE Seto
Oct 20, 2004·International Journal of Oncology·Masuko Katoh, Masaru Katoh
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Socorro María Rodríguez-PinillaJosé Palacios
Oct 31, 2006·Nature Cell Biology·Jong In YookStephen J Weiss
Jun 19, 2008·Breast Cancer Research : BCR·Gabriella HonethCecilia Hegardt
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Joseph H TaubeSendurai A Mani
Feb 25, 2011·Cancer Research·Yuanyuan QiaoQiang Yu
Apr 22, 2011·Trends in Genetics : TIG·Bérénice A BenayounReiner A Veitia
Feb 23, 2012·Scientific Reports·Robin M HallettJohn A Hassell
Oct 2, 2012·Cancer Letters·Masuko KatohMasaru Katoh
Jan 8, 2013·Nature Structural & Molecular Biology·Seo-Hee YouMitchell A Lazar
Mar 31, 2015·Nature Communications·Simon JunankarAlexander Swarbrick
Apr 8, 2015·Breast Cancer Research : BCR·Qing-Shan WangYu-Mei Feng
Jun 14, 2015·The Journal of Biological Chemistry·Hong-Pan TianYu-Mei Feng
Jan 6, 2016·Proceedings of the National Academy of Sciences of the United States of America·Olaia A Martínez-IglesiasAna Aranda
Mar 25, 2017·Cell·Denes HniszPhillip A Sharp

❮ Previous
Next ❯

Citations

Jun 22, 2019·Nature Communications·Shuo WangYu-Mei Feng
Jun 7, 2020·Cell Death & Disease·Weihan HeWeihua Guo
Apr 27, 2021·Frontiers in Cell and Developmental Biology·Jingyue XuRulang Jiang
Oct 29, 2021·Bioscience Reports·Pallabi DebnathSantanu Palchaudhuri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.